EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Activities of Recombinant Botulinum Toxin A on Spared Nerve Injury-Induced Neuropathic Pain in a Diabetic Mice Model

Akinyemi Ademola Omoniyi, Rasmus Eich Hammer iD, Sabrina Josefsen iD, Mette Richner, Stephane Lezmi, Christian Bjerggaard Vægter iD, Mikhail Kalinichev iD, Páll Karlsson, Jens Randel Nyengaard iD

Toxins · 2025

DOI: 10.3390/toxins17110545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, 2025. Verfasst von Akinyemi Ademola Omoniyi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Core Center for Molecular Morphology, Section for Stereology and Microscopy, Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denma…. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Diabetes Mellitus, Experimental, Neuralgia, Diabetic Neuropathies. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ipsen Innovation, Les Ulis/Saclay, France, Ipsen Bioinnovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic neuropathy is characterized by nerve damage and chronic neuropathic pain and lacks effective treatment. Botulinum neurotoxin type A (BoNT/A), a neurotoxin with established therapeutic use in neurological disorders, has emerged as a potential analgesic agent. This study investigated the effects of a recombinant form of BoNT/A1 (rBoNT/A1) on neuropathic pain induced by spared nerve injury (SNI) in a diabetic mouse model. Thirty-two adult male C57BL/6JRj diabetic mice were subjected to SNI or sham surgery. Fourteen days post surgery, mice received an intraplantar dose of rBoNT/A1 or vehicle. Mechanical allodynia was assessed using von Frey filaments, and spinal cord and sciatic nerve tissues were analyzed via immunohistochemistry and transmission electron microscopy to evaluate glial activation, neurotransmitter receptor expression, and axonal morphology. The results demonstrated that rBoNT/A1 significantly alleviated mechanical allodynia and caused a marked reduction in Iba1-positive microglial activation in the spinal cord, whereas no significant changes were observed in astrocyte (GFAP) density or GABAAR subunit expression. Additionally, rBoNT/A1 treatment did not significantly alter axon diameter, myelin thickness, or C-fiber morphology. In conclusion, intraplantar administration of rBoNT/A1 reduced SNI-induced mechanical allodynia in diabetic mice, potentially by attenuating spinal microglial activation, supporting the therapeutic promise of rBoNT/A1 in managing diabetic neuropathic pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ADiabetes Mellitus, ExperimentalNeuralgiaDiabetic NeuropathiesAnalgesicsAnimalsMaleMice, Inbred C57BLSciatic NerveSpinal CordHyperalgesiaRecombinant ProteinsMiceDisease Models, AnimalMicroglia

Stichwörter der Autor:innen

GFAPIba1astrocytesdiabetic neuropathymicrogliaperipheral nervous systemvon Frey

Substanzen

Botulinum Toxins, Type ARecombinant ProteinsAnalgesics

Autor:innen und Institutionen

  • Core Center for Molecular Morphology, Section for Stereology and Microscopy, Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark.
  • Department of Human Anatomy, Ahmadu Bello University, Zaria 810001, Nigeria.
  • Danish Research Institute of Translational Neuroscience (DANDRITE), Nordic-EMBL Partnership for Molecular Medicine, Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark.
  • Ipsen Innovation, Avenue du Canada, 91940 Les Ulis, France.
  • Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, 8000 Aarhus C, Denmark.
  • Department of Pathology, Aarhus University Hospital, 8200 Aarhus N, Denmark.

ORCID-Profile: Rasmus Eich Hammer, Sabrina Josefsen, Christian Bjerggaard Vægter, Mikhail Kalinichev, Jens Randel Nyengaard

Förderung

  • Ipsen Innovation, Les Ulis/Saclay, France
  • Ipsen Bioinnovation

Zitieren

APA

Omoniyi, A. A., Hammer, R. E., Josefsen, S., Richner, M., Lezmi, S., Vægter, C. B., Kalinichev, M., Karlsson, P., & Nyengaard, J. R. (2025). The Activities of Recombinant Botulinum Toxin A on Spared Nerve Injury-Induced Neuropathic Pain in a Diabetic Mice Model. Toxins. https://doi.org/10.3390/toxins17110545

Vancouver

Omoniyi AA, Hammer RE, Josefsen S, Richner M, Lezmi S, Vægter CB, et al. The Activities of Recombinant Botulinum Toxin A on Spared Nerve Injury-Induced Neuropathic Pain in a Diabetic Mice Model. Toxins. 2025. doi:10.3390/toxins17110545

BibTeX
@article{Omoniyi2025,
  author = {Omoniyi, Akinyemi Ademola and Hammer, Rasmus Eich and Josefsen, Sabrina and Richner, Mette and Lezmi, Stephane and Vægter, Christian Bjerggaard and Kalinichev, Mikhail and Karlsson, Páll and Nyengaard, Jens Randel},
  title = {The Activities of Recombinant Botulinum Toxin A on Spared Nerve Injury-Induced Neuropathic Pain in a Diabetic Mice Model},
  journal = {Toxins},
  year = {2025},
  doi = {10.3390/toxins17110545}
}
Kostenlos starten →